Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Origuchi

Showing results (161-170 of 227) with videos related to

Pageof 23
Sort By:
Arthritis Research & Therapy|December 15, 2016
Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 yearsShoichi Fukui, Naoki Iwamoto, Toshimasa Shimizu, et al.
Internal Medicine (Tokyo, Japan)|May 22, 2018
Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive TherapyYuya Fujita, Shoichi Fukui, Midori Ishida, et al.
Internal Medicine (Tokyo, Japan)|August 28, 2018
Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus InfectionToshimasa Shimizu, Naoki Iwamoto, Momoko Okamoto, et al.
Modern Rheumatology|September 8, 2011
Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factorsJunko Kita, Mami Tamai, Kazuhiko Arima, et al.
Internal Medicine (Tokyo, Japan)|January 12, 2018
Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with RituximabYuya Fujita, Shoichi Fukui, Yushiro Endo, et al.
Scientific Reports|January 26, 2019
Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosisShoichi Fukui, Ayako Kuwahara-Takaki, Nobuyuki Ono, et al.
Scientific Reports|June 13, 2020
Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosisShoichi Fukui, Shimpei Morimoto, Kunihiro Ichinose, et al.
Journal of Bone and Mineral Metabolism|September 7, 2018
Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugsNaoki Iwamoto, Momoko Okamoto, Sosuke Tsuji, et al.
Arthritis Care & Research|February 27, 2018
Ultrasonographic Efficacy of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis From a Multicenter Rheumatoid Arthritis Ultrasound Prospective Cohort in JapanAyako Nishino, Shin-Ya Kawashiri, Tomohiro Koga, et al.
Clinical Immunology (Orlando, Fla.)|October 9, 2018
Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritisKunihiro Ichinose, Mineaki Kitamura, Shuntaro Sato, et al.
Pageof 23

Showing results (161-170 of 227) with videos related to

Sort By:
Pageof 23
Arthritis Research & Therapy|December 15, 2016
Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 yearsShoichi Fukui, Naoki Iwamoto, Toshimasa Shimizu, et al.
Internal Medicine (Tokyo, Japan)|May 22, 2018
Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive TherapyYuya Fujita, Shoichi Fukui, Midori Ishida, et al.
Internal Medicine (Tokyo, Japan)|August 28, 2018
Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus InfectionToshimasa Shimizu, Naoki Iwamoto, Momoko Okamoto, et al.
Modern Rheumatology|September 8, 2011
Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factorsJunko Kita, Mami Tamai, Kazuhiko Arima, et al.
Internal Medicine (Tokyo, Japan)|January 12, 2018
Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with RituximabYuya Fujita, Shoichi Fukui, Yushiro Endo, et al.
Scientific Reports|January 26, 2019
Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosisShoichi Fukui, Ayako Kuwahara-Takaki, Nobuyuki Ono, et al.
Scientific Reports|June 13, 2020
Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosisShoichi Fukui, Shimpei Morimoto, Kunihiro Ichinose, et al.
Journal of Bone and Mineral Metabolism|September 7, 2018
Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugsNaoki Iwamoto, Momoko Okamoto, Sosuke Tsuji, et al.
Arthritis Care & Research|February 27, 2018
Ultrasonographic Efficacy of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis From a Multicenter Rheumatoid Arthritis Ultrasound Prospective Cohort in JapanAyako Nishino, Shin-Ya Kawashiri, Tomohiro Koga, et al.
Clinical Immunology (Orlando, Fla.)|October 9, 2018
Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritisKunihiro Ichinose, Mineaki Kitamura, Shuntaro Sato, et al.
Pageof 23